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Abstract
Background: Kru ¨ppel-like factor-6 (KLF6) is a widely expressed member of the Sp1/KLF family of transcriptional regulators
involved in differentiation, cell cycle control and proliferation in several cell systems. Even though the highest expression
level of KLF6 has been detected in human and mice placenta, its function in trophoblast physiology is still unknown.
Methodology/Principal Findings: Herein, we explored KLF6 expression and sub-cellular distribution in human trophoblast
cells differentiating into the syncytial pathway, and its role in the regulation of genes associated with placental
development and pregnancy maintenance. Confocal immunofluorescence microscopy demonstrated that KLF6 is expressed
throughout human cytotrophoblast differentiation showing no evident modifications in its nuclear and cytoplasmic
localization pattern. KLF6 transcript and protein peaked early during the syncytialization process as determined by qRT-PCR
and western blot assays. Overexpression of KLF6 in trophoblast-derived JEG-3 cells showed a preferential nuclear signal
correlating with enhanced expression of human b-chorionic gonadotropin (bhCG) and pregnancy-specific glycoprotein
(PSG) genes. Moreover, KLF6 transactivated bhCG5, PSG5 and PSG3 gene promoters. Deletion of KLF6 Zn-finger DNA binding
domain or mutation of the consensus KLF6 binding site abolished transactivation of the PSG5 promoter.
Conclusions/Significance: Results are consistent with KLF6 playing a role as transcriptional regulator of relevant genes for
placental differentiation and physiology such as bhCG and PSG, in agreement with an early and transient increase of KLF6
expression during trophoblast syncytialization.
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Introduction
Trophoblast is the first cell lineage to differentiate during
mammalian development. They are the precursor cells of the human
placenta, mediate implantation and give rise to most of the
extraembryonic tissues. After the initial phase of nidation, human
cytotrophoblast (CTB) cells differentiate along two pathways: the
invasive pathway to become extravillous trophoblasts or the syncytial
pathway to become villous trophoblasts. Extravillous trophoblasts
invade deep into the uterus wall and are directly implicated in
anchoring the chorionic villi in the uterus. The villous CTB cells in
the syncytial pathway fuse and differentiate into the syncytiotropho-
blast (STB) layer, which is a multinucleated epithelium-like surface
maintained by continuous cell fusion of the underlying mononuclear
CTBs. The STB plays a major role throughout pregnancy, as it is the
primary site for maternal–fetal exchange of nutrients, gas, and waste
products, and for the synthesis of hormones required for fetal growth
and development (reviewed in [1]). Placenta development and
trophoblast differentiation are associated with the up-regulation of a
number of genes regarded as pregnancy specific; among them are the
hCG and PSG gene families and the glial cell missing homolog 1
(GCM1) gene which encodes a transcription factor essential for STB
differentiation [2]. hCG has a central role in the formation of human
placental syncytium and pregnancy maintenance, indeed aberrant
serum levels are largely used to monitor pregnancy-associated
complications [3,4]. Multiple variants of hCG have been described
with relevant functions in the villous CTB and STB cells, as well as in
the extravillous invasive CTB cells [5]. hCG is composed of a specific
b-subunit and an a-subunit common to FSH, LH, and TSH [5].
Synthesis of the b-subunit is associated with fusion of CTBs into the
multinuclear syncytium. It is encoded by the bhCG gene cluster,
which comprises six members arranged on chromosome 19, being
bhCG5 gene the most abundantly transcribed in choriocarcinoma
cells and placenta [4]. The human PSG family is composed of 11
similar genes, also arranged on chromosome 19, whose expression is
markedly induced upon early trophoblast differentiation. They
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maternal circulation in late pregnancy and are also essential for
maintenance of gestation [6,7]. Although PSG genes share more than
93% nucleotide sequence identity, some of them are highly expressed
(i.e. PSG1, PSG3 and PSG5) while others remain low-expressed in
STB cells [7].
KLF6 is a member of the Kru ¨ppel-like transcription factor family
which has been independently cloned from placenta [8], leukocyte [9]
and liver [10] cDNA libraries. KLF6 is evolutionarily conserved and
broadlyexpressed in numerouscelltypes and at several developmental
stages, although its transcript is enriched in liver, prostate, lung and
placenta [8,11,12,13,14,15]. This protein has three C2H2 zinc fingers
at its C-terminal domain, responsible for specific DNA-binding to
either GT/GC-box or CACC-element sites on responsive promoters.
Experiments in several cell systems have revealed a general and
sometimes dissimilar role for KLF6 in the regulation of cellular events
as proliferation, differentiation and apoptosis [16]. KLF6 has been
mainly implicated as a tumor suppressor gene, frequently inactivated
in a variety of human cancers (reviewed in [17]). Nevertheless, several
other large studies established that genetic alterations of KLF6 are
rarely found in distinct types of human cancers. Moreover, it has been
reported that KLF6 gene expression was enhanced or its sub-cellular
localization was modified in some tumors [18,19,20,21]. Current
available information strongly suggests that the final outcome of KLF6
function depends on the particular cell environment, biochemical
signaling, interaction with specific transcriptional partners and/or its
sub-cellular distribution [21].
Klf62/2 knockout mice die by embryonic day 12.5 and are
characterized by reduced hematopoietic differentiation in yolk sacs
and impaired placental development [22]. Despite the fact that
KLF6 is highly expressed in human and mice placenta tissue
[8,12,23], little is known about its expression during villous
trophoblast cell differentiation and about its role in the
transcription of placenta specific genes.
The aim of this work was to explore KLF6 expression in human
trophoblast cells undergoing differentiation into the syncytial
pathway, and to provide evidence for its role as a transcriptional
regulator of genes involved in placenta and maintenance of
pregnancy.
Results
KLF6 protein is expressed throughout the CTB
differentiation into the syncytial pathway
KLF6 has been detected in villous trophoblast cells with a
nuclear and cytoplasmic signal, [21,23] however, it is not known
whether KLF6 is expressed through the whole syncytialization
process and if it maintains the same nucleo-cytoplasmic pattern.
Therefore, CTB cells were isolated from human normal-term
placenta and cultured, as previously described [7]. KLF6 protein
was detected during the entire differentiation process by
immunofluorescence assays, as visualized by conventional epi-
fluorescence microscopy (Fig 1A). Confocal immunofluorescence
microscopy revealed a cytoplasmic as well as nuclear staining in
CTB cells at several time points of the differentiation process
(Fig 1B). The presence of KLF6 in the nucleus was clearly
observed performing fluorescence intensity profiles where the
green peak (KLF6 signal) matches with the red peak (nuclear
signal) (Fig 1C). Morphological and biochemical differentiation of
CTBs into the STB pathway was corroborated by fluorescence
staining for nuclei, desmosomes and PSG proteins (Fig 1D), as well
as by the increase in PSG and bhCG mRNA levels (data not
shown). In sum, these results established that KLF6 is expressed
throughout the differentiation of CTB cells into the syncytial
pathway and that it is localized to both the nucleus and the
cytoplasm during this process.
Early and transient increase of KLF6 transcript and
protein levels during CTB cell differentiation
KLF6 transcript expression was evaluated by qRT-PCR assays
at different times during the in vitro CTB differentiation process.
KLF6 mRNA was detected in freshly isolated CTBs, its expression
was induced more than 2-fold after 2 h of differentiation, then
decreased over the next 16 h, increasing then again by an amount
dependent on the placenta evaluated (Fig 2A). Furthermore, KLF6
protein was also early induced during CTB differentiation
reaching a peak at 2 h that was near 3.5 fold greater than the
baseline levels and decreased by 80% over the next 16 h,
increasing again from that point with a similar kinetic to that
observed for mRNA (Fig 2B). Altogether these data indicate that
KLF6 expression is regulated during syncytialization, exhibiting
an early and transient increase followed by a less consistent
increase towards 72 h of differentiation, where syncytium-like
structures were clearly formed. These results suggest that KLF6
may be involved in the transcriptional control of genes associated
with or expressed in syncytial trophoblast.
KLF6 induces mRNA and protein expression of
trophoblast differentiation marker genes
There is a growing list of KLF6 target genes involved in cellular
growth, differentiation, adhesion and endothelial motility, as well
as metabolism and inflammation [17]. Although KLF6 was
isolated by target site screening of a placental expression library
using a PSG5 gene promoter element as a probe [8], there is
limited evidence demonstrating that KLF6 indeed regulates PSG
or other placental relevant genes in trophoblastic cells. The
trophoblast-related JEG-3 cell line was selected to analyze the role
of KLF6 as transcriptional regulator of trophoblastic genes. We
considered this cell line a suitable model because in normal culture
conditions they express low levels of PSG and bhCG. In addition,
they form syncytium-like structures and up-regulate the expression
of both genes when they are cultured in the presence of
methotrexate [7]. Furthermore, herein we demonstrate that
KLF6 basal expression is low in JEG-3 cells but it is also increased
when they are stimulated to differentiate with methotrexate
(Fig 3A). Thus, JEG-3 cells were transiently transfected with the
pXJ-41-KLF6 expression vector and the mRNA and protein levels
of relevant placental genes were evaluated 24 hours later. KLF6
overexpression induced an increase in PSG and bhCG mRNA
levels near 3- and 8-fold over the control, respectively (Fig. 3B). In
addition, the expression of the GCM1 transcription factor was
slightly but significantly stimulated (1.5-fold, p,0.05). Western
blot analysis showed that PSG and bhCG protein levels were
significantly higher in transfected cells relative to control cells,
while GCM1 protein expression remained unmodified (Fig. 3C).
KLF6 effect on the activation of bhCG synthesis was further
demonstrated by co-immunofluorescense assays of JEG-3 cells
transiently transfected with the pXJ-41-KLF6 expression plasmid.
Protein overexpression and nuclear localization of KLF6 were
confirmed by western blot and immunofluorescence assays,
respectively (Fig. 3C & D). As depicted in figure 3D, transfected
cells showed a clear increase in KLF6 signal (arrowheads)
compared with untransfected cells where a very low signal was
detected. Accordingly, cells clearly positive for bhCG (arrows)
were those overexpressing KLF6. In sum, these results provide
strong evidence for a role of KLF6 as a regulator of important
syncytium-related genes.
KLF6 Activates bhCG and PSG in Human Trophoblast
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trophoblastic cells
To analyze whether the induction of bhCG and PSG mRNA
levels by KLF6 involves the transcriptional activation of their
promoters, JEG-3 cells were co-transfected with the KLF6
expression plasmid and different bhCG5, PSG3 and PSG5 promoter
constructs coupled to a luciferase reporter gene. Reporter activity of
the promoter constructs containing nt 23700/+114 and 2345/
+114ofbhCGwasincreasedinKLF6overexpressingcellscompared
to cells transfected with the empty expression vector (Fig. 4A). No
differences were found in fold activation between the short (1.960.1
fold, p,0.01) and long (1.860.2 fold, p,0.01) bhCG5 promoter
constructs. Therefore, KLF6 is able to transactivate the bhCG5 gene
through sequences present in the 2345/+114 promoter region.
We have previously demonstrated that in non-placental COS-7
cells, PSG5 minimal promoter construct activity depends on a core
promoter element (CPE) recognized in vitro by a recombinant
KLF6-bgalactosidase fusion protein, and this activity was slightly
induced by overexpressing KLF6 [8,24,25]. Herein, we analyzed
whether KLF6 is a transcriptional activator of the PSG5 and PSG3
promoters in trophoblastic cells. Both genes share near 94%
identity in their promoter sequences and their KLF6 consensus
binding motifs (CPE) differ in two nucleotides, one in the core and
the other in the surrounding sequence. The PB5-luc (PSG5 nt
2605/249) and the PB3-luc (PSG3 nt 2613/249) promoter
constructs were activated by KLF6 overexpression in a dose-
dependent manner (Fig. 4B). In the presence of 150 ng of the
expression vector PB5-luc was activated 3.360.4 fold, while the
PB3-luc construct was activated 1.560.2 fold. Co-transfection
experiments performed with a KLF6 expression vector lacking the
three zinc-finger domains revealed that the KLF6 DNA binding
domain is required for PSG3 and PSG5 promoter transactivation
(Fig. 4B lanes DZF1-3). In addition, KLF6 also enhanced the
promoter activity of a shorter PSG5 regulatory region (nt 2251/
249) and this transactivation was markedly reduced when the
CPE consensus motif was mutated (Fig. 4B, UB5-luc compared to
UB5mut-luc).
These results support the role of KLF6 as a regulator of PSG
and bhCG gene transcription in the context of trophoblast cells.
Additionally, they indicate that PSG gene transactivation requires
Figure 1. KLF6 protein expression throughout trophoblast cell differentiation. A- Isolated mononuclear villous CTB cells cultured during
the indicated hours and stained for KLF6 immunofluorescence detection (middle panels) with the polyclonal R-173 (green) anti-KLF6 antibody. Nuclei
were counterstained with Hoechst 33342 dye (blue) and the overlay is shown (right panels). B- Confocal microscopy imaging of KLF6 at the indicated
time points of the differentiation process. KLF6 was labelled with the polyclonal R-173 antibody (left panels) and DNA was stained with propidium
iodide (IP) (middle panel). Overlay is shown in the right panels. C- Fluorescence intensity profile of KLF6 (green) and IP (red) along the yellow line
shown in the confocal microscopy images. D- Morphological and biochemical differentiation of isolated mononuclear CTB cells were confirmed by
the disappearance of desmoplakin intercellular staining (red), the appearance of multinucleated structures and the expression of PSG proteins
(green). Original magnification, x1000. Scale bar, 10 mm. Immunofluorescence assays were performed with at least three different CTB purifications
and representative figures are shown.
doi:10.1371/journal.pone.0022438.g001
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sequence, at least for the PSG5 gene.
Discussion
This study demonstrates that KLF6 is present in the nucleus
and cytoplasm of trophoblast cells throughout the syncytialization
process; KLF6 expression shows an early and transient increase
during differentiation, and it functions as a transcriptional
activator of bhCG5, PSG5 and PSG3 genes in a trophoblastic cell
line. In addition, the KLF6 Zn-finger DNA binding domain is
required for PSG gene transactivation.
Although KLF6 primary amino acid sequence analysis reveals a
conserved nuclear localization signal and predicts its nuclear
localization, KLF6 is frequently detected in the cytoplasm of
several tissues and cell lines [21]. KLF6-SV1 is a splice variant
which encodes for a truncated KLF6 protein with a novel C-
terminal domain mainly associated with a cytoplasmic localization
[26,27]. Thus, it is possible to postulate that the KLF6 cytoplasmic
signal observed in trophoblast cells could be the protein product of
this spliced variant. However, KLF6-SV1 mRNA and protein
were not detected in trophoblastic cells by semiquantitative PCR
or western blot assays, respectively (data not shown), suggesting
that it is not the main source of cytoplasmic KLF6 in placenta. It
has been reported that KLF6 is relocated from the cytoplasm to
the nucleus in response to different stimuli. For instance, KLF6
was found to be distributed in the cytoplasm of human umbilical
vein endothelial cells and was shifted from the cytoplasm to nuclei
after injury followed by the transactivation of the endoglin
promoter [28]. Even though we cannot rule out an enrichment
of KLF6 within the cell nucleus at some point of the syncytializa-
tion pathway, KLF6 was indeed located in the nucleus of
trophoblast cells throughout the differentiation process allowing
it to function as a transcription factor. In addition, it is possible to
postulate that KLF6 may participate in other biological processes
in the cytoplasm. This hypothesis is in line with recent findings
which demonstrate that cytoplasmic KLF6 is able to interact with
c-Src protein and thereby to interfere with estrogen receptor
alpha-mediated cell growth of breast cancer cells [29].
It has been previously demonstrated that KLF6 is co-expressed
with PSG in membranes and placenta tissues suggesting a function
as a regulator of PSG gene transcription in-vivo [23]. Herein, we
provide evidence for a role of KLF6 as transcriptional activator
not only of PSG3 and 5 genes but also of bhCG5 gene promoters in
trophoblastic cells. Although we have not investigated the
molecular mechanism involved, present results indicate that, at
least for PSG5, transactivation was dependent on the KLF6 Zn-
finger C-terminal domain and the CPE-box, a GC-rich element,
present in the PSG promoters. Results are compatible with KLF6
acting as a nuclear DNA-binding transcription factor. However,
the DZF1-3 KLF6 construct employed in our studies lacks the Zn-
finger domain and its 59 adjacent sequence, which was recently
demonstrated to be required for KLF6 translocation to the nucleus
[27]. Therefore, we cannot discard the possibility that KLF6 may
transactivate the PSG and bhCG promoters not through the direct
binding to its consensus sites, but through the association with
other transcription factors recruiting KLF6 to the regulatory
region of their target genes. In support of this hypothesis, PSG5
and bhCG5 promoters are also regulated by the Sp1 transcription
factor [4,30] and additionally, functional cooperation between
KLF6 and Sp1 is important for the transcriptional regulation of
some common target genes. This cooperation involves the physical
interaction between Sp1 C-terminal transactivating domain and
KLF6 N-terminal DNA binding domain [28,31]. Thus, in the
nucleus, KLF6 might directly recognize its binding site and/or
interact with Sp1 enhancing PSG and bhCG gene transcription.
Transient overexpression of KLF6 stimulated endogenous PSG
and bhCG mRNAs and induced a marked increase in their
protein levels, emphasizing KLF6 contribution to the activation of
PSG and bhCG expression in trophoblastic cells. In addition, KLF6
overexpression lead to a slight but significant increase in the
endogenous GCM1 mRNA with no apparent effect at the protein
level. The absence of an absolute correlation between the
Figure 2. KLF6 transcript and protein levels increase during
trophoblast cell differentiation. A- KLF6 mRNA expression was
quantified by qRT-PCR (ABI 7500, Applied Biosystems) in CTB cells
isolated from three to eight normal term placentas, and cultured in
differentiating medium during the indicated times. Results were
normalized to cyclophilin A and expressed according to the 2
2DDCt
method using as calibrator the expression level at 0 h. Results are
depicted as boxplot graphs representing the medians (horizontal bars),
the 25–75th percentile interquartile range (box limits), and the lowest
and highest values (whiskers) of three to eight experiments performed
in triplicates. Inter-group comparisons were made using the Kruskal-
Wallis one-way Analysis of variance (ANOVA) with the Dunn’s multiple
comparisons post-hoc test of statistical significance. *p,0.05 vs 0h ,
#p,0.05 vs 2h .B- Protein extracts (60 mg) prepared from CTB cells
cultured for the indicated hours were subjected to western blot analysis
using anti-KLF6 and a-tubulin antibodies as described in Materials and
Methods. A representative blot is shown. The bar graph represents the
densitometric quantification of KLF6/a-tubulin ratio of three indepen-
dent experiments expressed as mean 6SEM. *p,0.05 vs 0h ,{p,0.05
vs 16 h. (Kruskal-Wallis, Dunn’s).
doi:10.1371/journal.pone.0022438.g002
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corresponding protein levels might reflect differences in their
mRNA and protein half lives. This finding is also in line with the
contribution of post-transcriptional mechanisms involved in the
control of these trophoblast markers. Indeed, bhCG and GCM1
expression is regulated at both the transcriptional and translational
level including ubiquitination and proteasome-mediated degrada-
tion in mice and human trophoblast cells [32,33,34].
KLF6 mRNA and protein levels change throughout syncytia-
lization indicating that its gene expression is regulated during this
process. To our knowledge this is the first report indicating an
increase in KLF6 expression associated to trophoblast differenti-
Figure 3. KLF6 regulates mRNA and protein expression of placental genes. A- JEG-3 cells were cultured in the presence of 1 mM
methotrexate to induce cell differentiation during the indicted times and KLF6 mRNA expression was quantified by qRT-PCR (ABI 7500, Applied
Biosystems). B- JEG-3 cells transfected with the empty (white bars) or the KLF6 expression vector (black bars) were harvested 24 h after transfection
and PSG, bhCG and GCM1 gene expression was quantified by qRT- PCR (ABI 7500, Applied Biosystems). For A and B, results were normalized to
cyclophilin A and expressed according to the 2
2DDCt method using as calibrator the mRNA level obtained from the control condition. Data are
presented as mean 6SEM of three independent experiments performed in triplicates and a one-sample t-test was used to determine whether
experimental values were significantly different from the control value set as 1 (*p,0.05). C- Western blot detection of KLF6, PSG, bhCG and GCM1 in
protein extracts of JEG-3 cells transfected with the empty (left lane) or KLF6 expression vector (right lane). a-tubulin was used as a loading control in
each assay. Representative western blots are shown and the bar graph shows the densitometric analysis of three different experiments. (*p,0.05) D-
JEG-3 cells were transiently transfected with the KLF6 expression vector and 24 h later they were immunostained for the detection of KLF6 (red) and
bhCG (green) with a monoclonal anti-KLF6 and a polyclonal anti-bhCG antibodies, respectively. Nuclei were counterstained with Hoechst 33342 dye
(blue), and the merge of the three channels is shown on the right side. Bar=10 mm. Original magnification:61000. Representative images from three
independent transfections are shown. Arrowheads, JEG-3 cells overexpressing KLF6; arrows, cells positive for bhCG.
doi:10.1371/journal.pone.0022438.g003
KLF6 Activates bhCG and PSG in Human Trophoblast
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22438ation into the syncytial pathway and opens up an avenue for future
research on the mechanisms implicated. In other cell models, the
expression of KLF6 is enhanced by Sp1, IGF-I and TGF-b1
[15,31,35]; and KLF6 protein stability is controlled by the JNK
and p38 pathways, as well as by its nucleo-cytoplasmic localization
domains [27,36].
KLF6 has been largely associated with tumor biology [16].
Nevertheless, accumulating evidence indicates that KLF6 may be
a general regulator of cell differentiation and organ development.
In this sense, KLF6 expression is developmentally regulated in the
mouse cornea, lens and during preadipocyte differentiation
[37,38,39]. Furthermore, studies in klf6-/- mice and embryonic
stem cells (ES) established that Klf6 promotes ES-cell proliferation
and differentiation in early stages. Subsequently, it contributes to
differentiation into mesoderm cells and finally, it plays a role in
both hematopoiesis and vasculogenesis [22]. In addition, it has
been recently demonstrated that Klf6 is essential for the
development of endoderm-derived organs and for hepatocyte
specification in mouse ES cells [40]. According to these published
data and to the findings described here, it is attractive to propose
that KLF6 participates not only in the differentiation of cells
derived from the epiblast lineage but also from the trophoecto-
derm. We are currently addressing the role of KLF6 in trophoblast
differentiation.
In conclusion, present results support a functional role for KLF6
in the regulation of placenta-specific marker genes, provide the
first direct evidence for a regulated expression of KLF6 during
CTB cell differentiation into the syncytial pathway, and reveal a
nuclear as well as cytoplasmic localization during this differenti-
ation process. Altogether, they support a role of KLF6 in human
placental development and function, and are in good agreement
with the impaired placental development found in Klf6-/-
knockout mice [22]. Finally, these findings provide the basis for
further studies to elucidate KLF6 function within the trophoblast
environment in order to understand the precise processes this
transcription factor modulates in the human placenta, where its
expression is highly enriched.
Materials and Methods
Ethics statement
This study was conducted with the ethics approval from the
Human Studies Committee of the Hospital Privado of Co ´rdoba,
Argentina (HP 4–112). Normal term placentas were collected from
Figure 4. KLF6 transactivates bhCG, PSG5 and PSG3 genes in human trophoblastic cells. The human wild-type KLF6 (KLF6) expression
plasmid, the Zn-finger deleted KLF6 (DZF 1–3) construct or the empty (-) expression vector were cotransfected into JEG-3 cells together with the
Renilla reporter plasmid and (A) the human bhCG5 promoter luciferase reporter plasmids: 23700bhCG5-luc and 2345bhCG5-luc or (B) the PSG5 or
PSG3 promoter constructs: PB5-luc, PB3-luc, UB5-luc and UB5mut-luc, as depicted on the left. PSG5 and PSG3 consensus KLF6 binding sites, as well as
putative KLF6 binding motifs in the bhCG5 gene are depicted as circles. Luciferase activity was normalized to Renilla activity. The KLF6 expression
plasmid quantity used is indicated. Results are expressed as fold activation respect to each promoter construct co-transfected with the empty vector.
Data from three or four experiments performed in duplicate are shown (mean 6SD). * Statistically significant difference (p,0.05) between the fold
activation of each construct in the presence respect to the absence of the expression vectors is shown.
doi:10.1371/journal.pone.0022438.g004
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placentas obtained after delivery were considered waste material
and were normally discarded, informed consent was not required
by the local ethic committee. Our IRB specifically waived the need
for consent.
Cytotrophoblast isolation, cell culture and differentiation
Tissues from normal term placentas (37–41 wk of pregnancy)
were obtained after cesarean delivery and processed within 30 min
after delivery. After removal of the cord, amniochorion, and
decidual layer, villous tissue free of visible infarct, calcification or
haematoma was sampled from the maternal-fetal interface. The
tissue was cut into small pieces and washed with 154 mmol/L
NaCl, to remove blood. CTBs were isolated according to the
protocol of Kliman [41], with the modifications previously
described [42]. Isolated trophoblasts (97% cytokeratin 7-positive
cells) were plated in keratinocyte growth medium (KGM,
Invitrogen) supplemented with 10% fetal bovine serum (FBS)
and antibiotics (100 U/mL penicillin/0.1 mg/mL streptomycin).
Culture medium was supplemented with 5 ng/mL of recombinant
human Epidermal Growth Factor (EGF, Invitrogen, Cat.
No. 10450-013) to enhance syncytialization [43], and cells were
maintained in culture for up to 114 h with complete medium
changed every 24 h. JEG-3 cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with antibiotics and 10%
FBS. When required, they were cultured in the presence of 1 mM
methotrexate to induce in vitro differentiation as described [7].
Immunofluorescence assays
Isolated CTB and JEG-3 cells were cultured on cover slips using
supplemented medium as described above. The cover slips were
washed three times with PBS and cells were fixed 20 min in 3%
paraformaldehyde at room temperature or 10 min in methanol at
220uC according to the antibody used. Immediately after, cells
were incubated 10 min with 10 mM ammonium chloride to
inhibit quenching, washed with PBS three times and permeabi-
lized for 20 min with 0.5% Nonidet P-40 in PBS or 7 min with
0.1% Triton 100X in PBS. Cells were then rinsed with PBS three
times, blocked with 2.5% normal goat serum in 0.2% Tween-20 in
PBS (PBST) and with 0.5% fish skin gelatin in PBST, and then
incubated with the following primary antibodies: rabbit polyclonal
anti-KLF6 (anti-Zf9, R-173, Santa Cruz Biotech; 1:50), mouse
monoclonal anti-KLF6 (clone 2c11, 1:150) whose specificity was
previously determined [36], mouse anti-desmosomal protein
(0.045 mg/mL, ZK-31, Sigma Chemical Co.; 1:400), rabbit
polyclonal anti-human chorionic gonadotropin (hCG, A0231,
Dako; 1:500), mouse monoclonal anti-cytokeratin 7 (Dako, Clone
OV-TL 12/30) and rabbit polyclonal anti-PSG (A0131, Dako;
1:100). Cells were washed with PBST, blocked as described above,
and incubated with the appropriate species-specific secondary
antibodies, either red Alexa Fluor 594-conjugated goat anti-mouse
IgG (Fab) or green Alexa Fluor 488-conjugated donkey anti-rabbit
IgG (Fab) (Molecular Probes) in a 1:720 final dilution. Negative
controls were performed replacing the primary antibodies with
buffer. These controls ruled out nonspecific staining of CTB and
JEG-3 cells by the secondary antibodies used (not shown). All
antibody incubations were carried out in a humidity chamber for
1 h at 37uC. Nuclei were counterstained with Ho ¨echst 33342
(Molecular Probes, Cat. H-21492) dye or propidium iodide
0.2 mg/mL depending on the microscope used for visualizing,
i.e., a Nikon optical microscope (Nikon eclipse TE2000-U, USA)
or a Confocal Olympus FLuoview 1000 microscope (Olympus),
respectively. Slides were mounted in Aqueous Mounting Medium
with fluorescence tracers (Fluor Safe, Calbiochem, Cat. 345789).
Western blotting
Whole protein extracts of JEG-3 and CTB cells were prepared in
5X Laemmli buffer containing 60 mM Tris-HCl pH 6.8, 10%
glycerol, 2% sodium dodecyl sulphate, 1% 2-b-mercaptoethanol
and 0.002% bromophenol blue. Total protein samples were
separated on a 10% SDS-PAGE, and proteins were transferred to
a nitrocellulose Hybond-ECL (Amersham Bioscience). The mem-
branes were blocked in 5% non-fat milk in TBS (20 mM Tris-HCl,
150 mM NaCl pH 7.8), supplemented with 0.1% Tween-20 (TBS-
T) 1 h at room temperature or overnight at 4uC according to the
antibodyused.Blotswereincubatedwithprimaryantibodiesdiluted
in 5% non-fat milk in TBS-T for 1 h at room temperature, except
for the anti-Zf9 antibody which was incubated overnight at 4uC.
The following antibodies were used: rabbit polyclonal anti-KLF6
(anti-Zf9, R-173, Santa Cruz Biotech.; 1:750), rabbit polyclonal
anti-PSG (anti b-1-glycoprotein, A0131, Dako;1:1000), rabbit
polyclonal anti-human chorionic gonadotropin (hCG; A0231,
1:2000, Dako), rabbit polyclonal anti-GCM1 (AB2, Sigma-Aldrich;
1:3000), mousemonoclonalanti-a-tubulin(Sigma–Aldrich;1:2000).
After washing, the blots were incubated with horseradish peroxi-
dase-conjugated donkey anti-rabbit or sheep anti-mouse IgG
secondary antibodies (Amersham Bioscience; 1:5000) in TBS-T,
at room temperature for 1 h. Protein-antibody complexes were
visualized using an enhanced chemiluminescence detection system
(SuperSignalWest Pico; Pierce) and exposed to Kodak T-Mat G/
RA film. Ponceau staining (0.2% Ponceau, 3% tricloroactic acid,
3% sulfosalicilic acid) was used to verify protein transference from
gel to nitrocellulose membrane.
Quantitative real time RT-PCR and semiquantitative
RT-PCR
Total RNA was extracted from cultured cells at the indicated
times using Trizol Reagent (Invitrogen). One microgram of total
RNA was reverse-transcribed in a total volume of 20 ml using
random primers (Invitrogen) and 50 U M-MLV reverse transcrip-
tase (Promega Corp.).
Primers were manually designed with the assistance of the
Netprimer software (PREMIER Biosoft International, Palo Alto,
CA), UCSC In-Silico PCR (UCSC Genome Browser website) and
Primer Express software (ABI, Applied Biosystems). Primer
sequences were compared against the human genomic and
transcript data base with the BLAST program [44] at the NCBI
Web site. KLF6-specific primers (KLF6-882 For and KLF6-960 Rev)
located in exons 2 and 3 of the human KLF6 gene [15] were
designed in order to amplify only the wild type or full length KLF6
transcript. A different pair of primers (KLF6-F701 and sv1FLF6-
R807) was designed to amplify the KLF6-SV1 splice variant
through conventional RT-PCR.
Specific transcripts were quantified by real time qRT-PCR (ABI
7500 Sequence Detection System, Applied Biosystems) using the
Sequence Detection Software v1.4. Experiments were performed
using 1x SYBR Green PCR Master Mix (Applied Biosystems).
Primer sequences and concentrations are indicated in Table 1.
The cycling conditions included a hot start at 95uC for 10 min,
followed by 40 cycles at 95uC for 15 s and 60uC for 1 min.
Specificity was verified by melting curve analysis and agarose gel
electrophoresis. Fold change in gene expression was calculated
according to the 2
2DDCt method [45]. Each sample was analyzed
in triplicate. No amplification was observed in PCR reactions
containing water or RNA samples incubated without reverse
transcriptase during cDNA synthesis as template.
Semiquantitative RT-PCR of PSG and bhCG transcripts were
performed in CTB cultures in order to confirm cell differentiation
as described [7].
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JEG-3 cells were transiently transfected with the pXJ-41-KLF6
or the DZF1-3 expression vectors containing the human wild type
full-length KLF6 or the three zinc-finger carboxy terminus-deleted
cDNAs, respectively [36]. The empty vector (pXJ-41) was used in
control transfections. Luciferase reporter constructs containing the
59 regulatory region of human bhCG5 gene, 23700bhCG5-luc
and 2345bhCG5-luc were kindly provided by Dr M Kno ¨fler.
Constructions of PB3-luc, PB5-luc, UB5-luc and UB5mut-luc
plasmids have been previously described [7,46]. PB3-luc and PB5-
luc contain the promoter and proximal regulatory region of PSG3
and PSG5 genes from positions 2613/249 and 2605/249,
respectively. UB5-luc contains the promoter region of PSG5
(2251/249) and UB5mut-luc has the CPE-sequence mutated
from 59 CCC CAC CCA T 39 to 59 CCC Cga tat c 39.
To overexpress KLF6, JEG-3 cells were seeded at a density of
5610
5 cells per 6-well culture plate. After 24 h, cells were
transfected with 4 ml of Lipofectamine 2000 reagent and 1500 ng
of the KLF6 expression vector or the control empty vector.
Similarly, for transactivation experiments JEG-3 cells were seeded
at a density of 1610
5 per well in 24-well plates, cultured for 24 h
and afterwards transfected with 1 ml of Lipofectamine 2000
reagent, 500 ng of each PSG or bhCG5 reporter construct, up to
300 ng of the expression or empty vector and 25 ng of the Renilla
normalizing vector. Forty-eight hours post-transfection, cells were
harvested and protein extracts were prepared in 100 ml of the
passive lysis buffer. As controls, cells were transfected with the
promoter-less luciferase vector (pGL3 basic). Luciferase and Renilla
activities were measured in 10 or 20 ml of protein extracts on a
GloMax-Multi Detection System (Promega Corp.) using the Dual-
Luciferase Reporter Assay System (Promega Corp.), according to
the manufacturer’s instructions. For each cell extract, luciferase
activity was normalized to Renilla activity and expressed as relative
light units (RLUs). Relative promoter activity was calculated as the
RLUs of each promoter construct in the presence, relative to the
absence, of the expression vector.
Statistical analysis
Results are presented as mean 6SEM or as median and range
of three to eight independent experiments performed in duplicates
or triplicates. A one-sample t-test was used to determine whether
experimental values were significantly different from fixed control
values set as 1. Nonparametric ANOVA was performed on
quantitative mRNA and protein expression levels of KLF6 in
CTBs during the differentiation time course using Kruskal-Wallis
one-way Analysis of variance (ANOVA) with the Dunn’s multiple
comparisons post-hoc test. Statistical analyses were performed
using the GraphPad Prism 5.0 software and p-values ,0.05 were
considered statistically significant.
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